Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer
| Image |  |
|---|---|
| Description | scientific article published on 23 October 2020 |
| Author/s |
author: Charles M. Perou Olwen Hahn David W Hillman Katherine A. Hoadley Sara M Tolaney Ian E Krop Mei-Yin Polley Ann Partridge Don Berry Lucas Huebner Clifford A Hudis N Lynn Henry Eric Winer Aranzazu Fernandez-Martinez |
| Publication date | October 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |